Acute Graft Rejection
11
1
1
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
18.2%
2 terminated out of 11 trials
77.8%
-8.7% vs benchmark
27%
3 trials in Phase 3/4
71%
5 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (11)
Silymarin's Advantage on Graft Effectiveness
A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf
Diagnosis of Graft Pathology by TruGraf
Pre-formed Alloreactivity in Renal Transplant Recipients
Detection of Acute Graft Rejection in Heart Transplant Patients by Estimation of T2
Kidney Transplant Failure
Magnetic Resonance Elastography of Cardiac Transplant Rejection
Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR
Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction
Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation
Comparison of Sirolimus and Azathioprine in Lung Transplantation